Iterative Design of a Prodrug Nanocarrier for Cell Cycle Arrest, Immune Modulation, and Enhanced T Cell Infiltration for Colon Cancer Therapy
Nano Letters · 2025
DOI: 10.1021/acs.nanolett.4c06018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, 2025. Verfasst von Zhenhan Feng und 10 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscien…. Hauptthemen laut MEDLINE: Prodrugs, Colonic Neoplasms, Cell Cycle Checkpoints, T-Lymphocytes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Chinese Academy of Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
- Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China.
- Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China.
- Department of Hepatobiliary and Pancreatic Surgery, Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Taikang Center for Life and Medical Sciences, Zhongnan Hospital of Wuhan University,…
- Institute of Breast Health Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610041, China.
ORCID-Profile: Zhenhan Feng, Meng Wang, Yuliang Zhao, Huan Meng
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Chinese Academy of Sciences
Zitieren
APA
Feng, Z., Qin, M., Jiang, J., Wang, M., Zhang, T., Li, Y., Liu, X., Zhang, J., Shi, H., Zhao, Y., & Meng, H. (2025). Iterative Design of a Prodrug Nanocarrier for Cell Cycle Arrest, Immune Modulation, and Enhanced T Cell Infiltration for Colon Cancer Therapy. Nano Letters. https://doi.org/10.1021/acs.nanolett.4c06018
Vancouver
Feng Z, Qin M, Jiang J, Wang M, Zhang T, Li Y, et al. Iterative Design of a Prodrug Nanocarrier for Cell Cycle Arrest, Immune Modulation, and Enhanced T Cell Infiltration for Colon Cancer Therapy. Nano Letters. 2025. doi:10.1021/acs.nanolett.4c06018
BibTeX
@article{Feng2025,
author = {Feng, Zhenhan and Qin, Mengmeng and Jiang, Jinhong and Wang, Meng and Zhang, Tianyu and Li, Yibo and Liu, Xiangsheng and Zhang, Jinfang and Shi, Hubing and Zhao, Yuliang and Meng, Huan},
title = {Iterative Design of a Prodrug Nanocarrier for Cell Cycle Arrest, Immune Modulation, and Enhanced T Cell Infiltration for Colon Cancer Therapy},
journal = {Nano Letters},
year = {2025},
doi = {10.1021/acs.nanolett.4c06018}
}
EUVIMED